CALL/MERCK & CO./200/0.1/21.06.24 Share Price

Warrant

DE000GP3YEJ1

Real-time BOERSE MUENCHEN 19:26:09 21/05/2024 BST
0.001 EUR 0.00% Intraday chart for CALL/MERCK & CO./200/0.1/21.06.24
6 months-50.00%
Date Price Change
21/05/24 0.001 0.00%
20/05/24 0.001 0.00%
17/05/24 0.001 0.00%
16/05/24 0.001 0.00%
15/05/24 0.001 0.00%

Real-time BOERSE MUENCHEN

Last update May 21, 2024 at 07:26 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Goldman Sachs
WKN GP3YEJ
ISINDE000GP3YEJ1
Date issued 03/05/2023
Strike 200 $
Maturity 21/06/2024 (31 Days)
Parity 10 : 1
Emission price 0.01
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.018
Lowest since issue 0.001

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131 USD
Average target price
141.6 USD
Spread / Average Target
+8.13%
Consensus